Related Experiment Video
Updated: Jun 9, 2026
15:57
Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
Interferon-gamma-release assays: Better than tuberculin skin testing?
Cyndee Miranda1, J Walton Tomford, Steven M Gordon
1Department of Infectious Disease, Medicine Institute, G21, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. mirandc@ccf.org
Cleveland Clinic Journal of Medicine
|September 3, 2010
Summary
The tuberculin skin test for latent tuberculosis infection has limitations. Interferon-gamma-release assays offer a valuable alternative for diagnosis and interpretation.
Area of Science:
- Immunology
- Infectious Diseases
- Diagnostic Medicine
Background:
- The tuberculin skin test (TST) is the traditional method for diagnosing latent tuberculosis infection (LTBI).
- TST presents limitations including cross-reactivity and need for patient follow-up.
- Interferon-gamma-release assays (IGRAs) have emerged as a promising alternative for LTBI detection.
Observation:
- This paper reviews clinical cases to demonstrate the application of IGRAs.
- The cases highlight practical scenarios for utilizing IGRA results.
- Interpretation of IGRA results in diverse clinical contexts is discussed.
Findings:
- IGRAs offer improved specificity compared to TST in certain populations.
- Case examples illustrate the utility of IGRAs in managing patients with suspected LTBI.
- Understanding IGRA performance characteristics is crucial for accurate diagnosis.
Implications:
- IGRAs represent a significant advancement in the diagnosis of latent tuberculosis infection.
- Clinicians can leverage IGRA results for more precise patient management.
- Wider adoption of IGRAs may improve tuberculosis control strategies.
